18
IRUS Total
Downloads
  Altmetric

Re-evaluating the genetic contribution of monogenic dilated cardiomyopathy

File Description SizeFormat 
DCM_manuscript_SuppNotes_FINAL.docxSupporting information28.06 MBMicrosoft WordView/Open
DCM_manuscript_SuppTables_FINAL.xlsxSupporting information258.07 kBMicrosoft Excel XMLView/Open
ReevalutingTheGeneticContribution.pdfPublished version863.24 kBAdobe PDFView/Open
Title: Re-evaluating the genetic contribution of monogenic dilated cardiomyopathy
Authors: Mazzarotto, F
Tayal, U
Buchan, RJ
Midwinter, W
Wilk, A
Whiffin, N
Govind, R
Mazaika, E
De Marvao, A
Dawes, T
Felkin, LE
Ahmad, M
Theotokis, PI
Edwards, E
Ing, AI
Thomson, KL
Chan, LLH
Sim, D
Baksi, AJ
Pantazis, A
Roberts, AM
Watkins, H
Funke, B
O'Regan, D
Olivotto, I
Barton, PJR
Prasad, SK
Cook, SA
Ware, JS
Walsh, R
Item Type: Journal Article
Abstract: Background: Dilated cardiomyopathy (DCM) is genetically heterogeneous, with >100 purported disease genes tested in clinical laboratories. However, many genes were originally identified based on candidate-gene studies that did not adequately account for background population variation. Here we define the frequency of rare variation in 2538 DCM patients across protein-coding regions of 56 commonly tested genes and compare this to both 912 confirmed healthy controls and a reference population of 60,706 individuals in order to identify clinically interpretable genes robustly associated with dominant monogenic DCM. Methods: We used the TruSight Cardio sequencing panel to evaluate the burden of rare variants in 56 putative DCM genes in 1040 DCM patients and 912 healthy volunteers processed with identical sequencing and bioinformatics pipelines. We further aggregated data from 1498 DCM patients sequenced in diagnostic laboratories and the ExAC database for replication and meta-analysis. Results: Truncating variants in TTN and DSP were associated with DCM in all comparisons. Variants in MYH7, LMNA, BAG3, TNNT2, TNNC1, PLN, ACTC1, NEXN, TPM1 and VCL were significantly enriched in specific patient subsets, with the last 2 genes potentially contributing primarily to early-onset forms of DCM. Overall, rare variants in these 12 genes potentially explained 17% of cases in the outpatient clinic cohort representing a broad range of adult DCM patients and 26% of cases in the diagnostic referral cohort enriched in familial and early-onset DCM. Whilst the absence of a significant excess in other genes cannot preclude a limited role in disease, such genes have limited diagnostic value since novel variants will be uninterpretable and their diagnostic yield is minimal. Conclusion: In the largest sequenced DCM cohort yet described, we observe robust disease association with 12 genes, highlighting their importance in DCM and translating into high interpretability in diagnostic testing. The other genes analysed here will need to be rigorously evaluated in ongoing curation efforts to determine their validity as Mendelian DCM genes but have limited value in diagnostic testing in DCM at present. This data will contribute to community gene curation efforts and will reduce erroneous and inconclusive findings in diagnostic testing.
Issue Date: 4-Feb-2020
Date of Acceptance: 14-Nov-2019
URI: http://hdl.handle.net/10044/1/75254
DOI: 10.1161/CIRCULATIONAHA.119.037661
ISSN: 0009-7322
Publisher: American Heart Association
Start Page: 387
End Page: 398
Journal / Book Title: Circulation
Volume: 141
Issue: 5
Copyright Statement: © 2020 The Authors. Circulation is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution ( https://creativecommons.org/licenses/by/4.0/ ) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Sponsor/Funder: British Heart Foundation
Wellcome Trust
British Heart Foundation
Medical Research Council (MRC)
Fondation Leducq
Fondation Leducq
Department of Health
Imperial College Healthcare NHS Trust- BRC Funding
British Heart Foundation
Imperial College Healthcare NHS Trust- BRC Funding
Commission of the European Communities
Wellcome Trust
British Heart Foundation
Rosetrees Trust
British Heart Foundation
Mason Medical Research Foundation
The Academy of Medical Sciences
Funder's Grant Number: SP/10/10/28431
107469/Z/15/Z
RG/19/6/34387
MR/M003191/1
11 CVD-01
11 CVD-01
HICF-R6-373
RDC04
NH/17/1/32725
RDB02
289600
100134/Z/12/Z
SP/17/11/32885
M735
RE/18/4/34215
N/A
SGL015/1006
Keywords: Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
Cardiovascular System & Hematology
1102 Cardiorespiratory Medicine and Haematology
Publication Status: Published
Online Publication Date: 2020-01-27
Appears in Collections:Institute of Clinical Sciences



Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.

Creative Commons